Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single nucleus RNA sequencing of juvenile dermatomyositis skeletal muscle identifies altered angiogenic signaling.

bioRxiv : the preprint server for biology·2026
Same author

What is the best way to plan a 12-month clinical drug trial in JIA associated uveitis?

Expert review of clinical immunology·2026
Same author

Global Perspectives on Paediatric Uveitis: Bridging the Divide in Child-Centered Ocular Care.

Ocular immunology and inflammation·2025
Same author

Validation of the Pediatric Arthritis Ultrasound Scoring System for the Elbow, Wrist, and Finger Joints in Children With Juvenile Idiopathic Arthritis.

Arthritis care & research·2025
Same author

Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood.

Arthritis care & research·2025
Same author

Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force.

Annals of the rheumatic diseases·2025

Related Experiment Video

Updated: Mar 19, 2026

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

4.3K

Uveitis in children.

Sheila T Angeles-Han1, Consuelo Egla Rabinovich

  • 1aEmory University School of Medicine, Atlanta, Georgia bDuke University, Durham, North Carolina, USA.

Current Opinion in Rheumatology
|June 22, 2016
PubMed
Summary

Identifying novel risk markers and advanced treatments for pediatric inflammatory uveitis is crucial. Early intervention for high-risk children can prevent severe disease and improve visual outcomes.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Inflammatory Diseases

Background:

  • Pediatric inflammatory uveitis can lead to vision-threatening complications.
  • Identifying children at risk for severe disease and poor visual outcomes is critical.
  • Traditional therapies may be insufficient for refractory cases.

Purpose of the Study:

  • To review novel risk markers for pediatric inflammatory uveitis.
  • To discuss treatments for refractory uveitis in children.
  • To highlight the importance of measuring visual outcomes and patient-reported outcomes.

Main Methods:

  • Literature review of recent advancements in pediatric uveitis.
  • Synthesis of current knowledge on risk stratification.
  • Discussion of emerging therapeutic agents and outcome measures.

More Related Videos

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis
06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

9.4K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

2.0K

Related Experiment Videos

Last Updated: Mar 19, 2026

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

4.3K
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis
06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

9.4K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

2.0K

Main Results:

  • New genetic markers, biomarkers, and clinical factors influencing disease course have been identified.
  • Racial disparities in pediatric uveitis have been reported.
  • Potential therapeutic agents and the significance of patient-reported outcomes are discussed.

Conclusions:

  • Timely and aggressive treatment for at-risk children can improve outcomes.
  • Identifying novel risk markers aids in early intervention for severe pediatric uveitis.
  • Focusing on visual and patient-reported outcomes is essential for comprehensive care.